A Innovative Web-based Dance Movement Therapy
Developing and Evaluating the Effect of a Innovative Web-based Dance Movement Therapy on Alexithymia and Frailty in Women With Breast Cancer: An Experimental Study
1 other identifier
interventional
67
1 country
1
Brief Summary
The goal of this clinical trial is to develop an innovative web-based dance movement therapy (DMT) training platform and assess short-term outcomes before and after its implementation in women with breast cancer Is the DMT training platform comprehensibility and acceptability among patients? Is the DMT training platform acceptability, usability, and feasibility among healthcare providers? Does the DMT training platform have effects on alexithymia and frailty among patients? Researchers will compare experimental to a control (a a conventional care program) to see if DMT training platform works to treat severe asthma. Participants will: receive an orientation on the web-based DMT program before chemotherapy, along with a single face-to-face traditional education session on physical activity . complete training sessions three times per week, with each session lasting at least 70 min.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable breast-cancer
Started Aug 2024
Shorter than P25 for not_applicable breast-cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
October 31, 2025
CompletedFirst Submitted
Initial submission to the registry
March 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 16, 2026
CompletedMarch 16, 2026
March 1, 2026
12 months
March 11, 2026
March 11, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Alexithymia
Alexithymia was assessed using the Chinese version of the Toronto Alexithymia Scale (TAS), a self-reported outcome measure \[30-31\]. The TAS consists of 20 items covering three key domains: difficulty in identifying and discriminating emotional cues, difficulty in verbally expressing emotions and feelings, and externally oriented thinking. Each item was rated on a 5-point Likert scale, ranging from 1 to 5, resulting in a total score range of 20 to 100, with higher scores indicating greater alexithymia.
one year (2024/08/01-2025/07/31)
Frailty
A breast cancer comprehensive frailty scale (BCCFS) was developed to assess frailty across three domains: deterioration in body function and mobility, negative emotional states, and cognitive impairment. The BCCFS comprises 16 items and has demonstrated strong psychometric properties, with a Cronbach's alpha of 0.91, indicating excellent internal consistency, and a test-retest reliability coefficient of 0.60 \[32\]. The validity and reliability of the BCCFS have been well established. Responses to each item were recorded on a five-point Likert scale, with higher scores indicating greater perceived frailty.
one year ( 2024/08/01-2025/07/31).
Study Arms (1)
The web-based DMT training intervention
EXPERIMENTALInterventions
Patients in the experimental group received an orientation on the web-based DMT program before chemotherapy, along with a single face-to-face traditional education session on physical activity. Participants were encouraged to complete training sessions three times per week, with each session lasting at least 70 min. Each DMT training session was divided into four components: (1) Proprioception; (2)Warm-up and stretching techniques; (3) Main part; (4) Relaxation.
Eligibility Criteria
You may qualify if:
- Patients who were about to start chemotherapy were recruited from a hospital in Taipei, Taiwan
You may not qualify if:
- major illness (e.g., heart failure, stroke, blindness) or a pre-existing mental disorder
- a history of limb amputation
- prior participation in dance therapy before their breast cancer diagnosis
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Chin-Tsung Shenlead
- Ministry of Science and Technology, Taiwancollaborator
Study Sites (1)
National Yang Ming Chiao Tung University
Taipei, Taiwan
Related Publications (1)
Abu-Odah H, Wang M, Su JJ, Collard-Stokes G, Sheffield D, Molassiotis A. Effectiveness of dance movement therapy and dance movement interventions on cancer patients' health-related outcomes: a systematic review and meta-analysis. Support Care Cancer. 2024 Mar 19;32(4):235. doi: 10.1007/s00520-024-08431-4.
PMID: 38502260BACKGROUND
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Academic Research Team Member
Study Record Dates
First Submitted
March 11, 2026
First Posted
March 16, 2026
Study Start
August 1, 2024
Primary Completion
July 31, 2025
Study Completion
October 31, 2025
Last Updated
March 16, 2026
Record last verified: 2026-03
Data Sharing
- IPD Sharing
- Will not share